US5075447A
(en)
*
|
1984-09-17 |
1991-12-24 |
Hoffmann-La Roche Inc. |
Ruthenium complexes useful as carriers for immunologically active materials
|
DK365785A
(da)
*
|
1984-09-17 |
1986-03-18 |
Hoffmann La Roche |
Metalcomplexer
|
US5585279A
(en)
*
|
1986-01-23 |
1996-12-17 |
Davidson; Robert S. |
Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
|
GB8601646D0
(en)
|
1986-01-23 |
1986-02-26 |
Davidson R S |
Binding assay & reagent
|
US6018030A
(en)
*
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
MX9203454A
(es)
|
1989-12-28 |
1992-08-01 |
Upjohn Co |
Compuestos anti sida diaromaticos substituidos.
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
WO1996013510A1
(en)
|
1994-10-28 |
1996-05-09 |
Procept, Inc. |
Ruthenium complexes and their use as immunosuppressive agents
|
US5708022A
(en)
*
|
1994-10-28 |
1998-01-13 |
Procept, Inc. |
Method for inhibiting immune response
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
US5831003A
(en)
|
1996-06-28 |
1998-11-03 |
Bayer Corporation |
Peptides which bind to prothrombin and thrombin
|
JP2002511934A
(ja)
|
1997-06-18 |
2002-04-16 |
ウルリッヒ・ジェイ・クルール |
核酸バイオセンサ診断装置
|
WO1999031513A1
(en)
|
1997-12-15 |
1999-06-24 |
Lakowicz Joseph R |
Method and composition for characterizing a sample containing a sample lipid and an assay kit
|
US6759243B2
(en)
*
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
ATE380865T1
(de)
*
|
1998-05-13 |
2007-12-15 |
Domantis Ltd |
Phagen-display-selektionssystem für korrekt gefaltete proteine
|
WO1999058546A1
(en)
*
|
1998-05-13 |
1999-11-18 |
Ludwig Institute For Cancer Research |
Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
|
US7037667B1
(en)
*
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
US7521197B2
(en)
*
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
US20020106678A1
(en)
|
1998-06-30 |
2002-08-08 |
Robishaw Janet D. |
cDNA clones encoding human G protein gamma subunits
|
CA2336475A1
(en)
|
1998-07-02 |
2000-01-13 |
Christopher J. Dinsmore |
Inhibitors of prenyl-protein transferase
|
US6288221B1
(en)
*
|
1998-08-20 |
2001-09-11 |
Duke University |
Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
|
AU6136599A
(en)
|
1998-09-08 |
2000-03-27 |
University Of Maryland At Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
US6806089B1
(en)
*
|
1998-09-08 |
2004-10-19 |
University Of Maryland, Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
AU1223400A
(en)
|
1998-10-22 |
2000-05-08 |
Phillip B. B. Moheno |
Novel pterin antineoplastic agents
|
IL145290A0
(en)
*
|
1999-03-19 |
2002-06-30 |
Anormed Inc |
Pharmaceutical compositions comprising complexes
|
US6872519B1
(en)
*
|
1999-04-27 |
2005-03-29 |
Mirus Bio Corporation |
In vitro process for selecting phage resistant to blood inactivation
|
US20090087878A9
(en)
*
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
US20030024579A1
(en)
|
1999-07-07 |
2003-02-06 |
Blackmore Donald Ian |
Diverter valve
|
GB9916529D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
BR0014078A
(pt)
|
1999-09-17 |
2002-12-31 |
Millennium Pharm Inc |
Inibidores de fator xa
|
WO2001046209A1
(en)
|
1999-12-20 |
2001-06-28 |
Fluorrx, Inc. |
Fluorescent probes
|
US20030219806A1
(en)
*
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
US7585839B2
(en)
*
|
2000-02-23 |
2009-09-08 |
Zealand Pharma A/S |
Medical uses of intercellular communication facilitating compounds
|
US20030215860A1
(en)
*
|
2000-02-29 |
2003-11-20 |
Millennium Pharmaceuticals, Inc. |
Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
|
US20030165831A1
(en)
*
|
2000-03-21 |
2003-09-04 |
John Lee |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
US7834146B2
(en)
*
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
JP2004515217A
(ja)
*
|
2000-06-16 |
2004-05-27 |
インサイト・ゲノミックス・インコーポレイテッド |
プロテアーゼ
|
AU2002214531A1
(en)
*
|
2000-07-03 |
2002-01-30 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20050053930A1
(en)
*
|
2000-07-18 |
2005-03-10 |
David Anderson |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6812339B1
(en)
*
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
US7264810B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
TWI329129B
(en)
*
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
US6783969B1
(en)
*
|
2001-03-05 |
2004-08-31 |
Nuvelo, Inc. |
Cathepsin V-like polypeptides
|
US7030236B2
(en)
|
2001-03-09 |
2006-04-18 |
Mona Savitri Jhaveri |
Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof
|
WO2002071928A2
(en)
|
2001-03-14 |
2002-09-19 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
US20030065157A1
(en)
*
|
2001-04-04 |
2003-04-03 |
Lasek Amy W. |
Genes expressed in lung cancer
|
EP2280030A3
(en)
*
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
JP2005527180A
(ja)
*
|
2001-04-18 |
2005-09-15 |
プロテイン デザイン ラブス, インコーポレイテッド |
肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法
|
CA2451465A1
(en)
*
|
2001-06-18 |
2002-12-27 |
Eos Biotechnology Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
US20040053824A1
(en)
*
|
2001-06-29 |
2004-03-18 |
Tang Y Tom |
Extracellular matrix and cell adhesion molecules
|
US20030099974A1
(en)
|
2001-07-18 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
|
ES2373644T3
(es)
|
2001-08-31 |
2012-02-07 |
Btg International Limited |
Uso de derivados de ciclopenta[g]quinazolina para el tratamiento del c�?ncer.
|
ATE483722T1
(de)
|
2001-08-31 |
2010-10-15 |
Btg Int Ltd |
Antikrebs-cyclopentaag chinazoline-derivate
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
US7622260B2
(en)
|
2001-09-05 |
2009-11-24 |
The Brigham And Women's Hospital, Inc. |
Diagnostic and prognostic tests
|
AR045702A1
(es)
*
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
AU2002360403A1
(en)
|
2001-11-19 |
2003-06-10 |
Elan Pharmaceuticals, Inc. |
(4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of Alzheimer's disease
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
US7803749B2
(en)
*
|
2002-01-09 |
2010-09-28 |
Xigen Sa |
Peptide inhibitors of MKK7 kinase binding to insulin binding proteins
|
WO2003062290A1
(en)
*
|
2002-01-16 |
2003-07-31 |
Biocompatibles Uk Limited |
Polymer conjugates
|
ES2426420T3
(es)
*
|
2002-01-28 |
2013-10-23 |
Keraplast Technologies Ltd. |
Péptidos de queratina bioactivos
|
US6962910B2
(en)
*
|
2002-02-01 |
2005-11-08 |
Virginia Tech Intellectual Properties, Inc. |
Supramolecular complexes as photoactivated DNA cleavage agents
|
AU2003225573A1
(en)
|
2002-02-13 |
2003-09-04 |
The Government Of The United States Of America As Represented By The Secretary, Department Of He |
Identification of ovarian cancer tumor markers and therapeutic targets
|
DE10206616A1
(de)
*
|
2002-02-15 |
2003-09-04 |
Qiagen Gmbh |
Verfahren zur Reduktion der Background-Kontamination nach Markierungsreaktionen
|
WO2003075952A1
(en)
|
2002-03-05 |
2003-09-18 |
Board Of Regents, The University Of Texas System |
Methods of enhancing immune induction involving mda-7
|
US20040101874A1
(en)
*
|
2002-04-12 |
2004-05-27 |
Mitokor Inc. |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
PL375064A1
(en)
*
|
2002-05-20 |
2005-11-14 |
Abgenix, Inc. |
Treatment of renal carcinoma using antibodies against the egfr
|
CA2500687A1
(en)
*
|
2002-10-02 |
2004-04-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP1422242A1
(en)
|
2002-11-22 |
2004-05-26 |
Emory University |
Plastic and elastic protein copolymers
|
US20060247193A1
(en)
*
|
2003-02-10 |
2006-11-02 |
National Institute Of Advanced Industrial Science And Technology |
Regulation of gene expression by dna interference
|
WO2004087874A2
(en)
|
2003-03-28 |
2004-10-14 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
US20060229433A1
(en)
*
|
2003-05-20 |
2006-10-12 |
Cellpep Sa |
Modified antiviral peptides with increased activity and cell membrane affinity
|
EP1636363A1
(en)
*
|
2003-05-21 |
2006-03-22 |
GeneSense Technologies Inc. |
Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
|
US20060078941A1
(en)
|
2003-06-09 |
2006-04-13 |
Santin Alessandro D |
Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
|
GB0314472D0
(en)
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
GB0318096D0
(en)
*
|
2003-08-01 |
2003-09-03 |
Queen Mary & Westfield College |
Vaccine
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
US20070178458A1
(en)
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
US20050147621A1
(en)
*
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
DE10347710B4
(de)
*
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
WO2005039504A2
(en)
|
2003-10-24 |
2005-05-06 |
Eisai Co., Ltd. |
Compounds and methods for treating toll-like receptor 2-related diseases and conditions
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
EP1547581A1
(en)
|
2003-12-23 |
2005-06-29 |
Vectron Therapeutics AG |
Liposomal vaccine for the treatment of human hematological malignancies
|
EP1550458A1
(en)
*
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
EP1756272A2
(en)
*
|
2004-01-09 |
2007-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
|
EP1747284A4
(en)
|
2004-02-06 |
2009-03-11 |
Wyeth Corp |
DIAGNOSTICS AND THERAPEUTICS OF CANCER
|
JP4912894B2
(ja)
|
2004-02-19 |
2012-04-11 |
イェール ユニバーシティー |
プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
|
JP2008509073A
(ja)
|
2004-03-01 |
2008-03-27 |
ペプテラ ファーマスーティカルズ エルティーディー. |
カゼイン由来ペプチドおよびその治療的使用
|
CA2558767A1
(en)
|
2004-07-06 |
2006-01-12 |
Warwick Effect Polymers Limited |
Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates anddrugs obtained therefrom
|
WO2007084413A2
(en)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
US7772271B2
(en)
*
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
US7553944B2
(en)
*
|
2004-07-21 |
2009-06-30 |
The University Of Hong Kong |
Human virus causing respiratory tract infection and uses thereof
|
WO2006026569A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Northeastern University |
Comprehensive characterization of complex proteins at trace levels
|
DE102004042546A1
(de)
*
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
JP2008512490A
(ja)
|
2004-09-08 |
2008-04-24 |
チェルシー・セラピューティクス,インコーポレイテッド |
異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
|
US8247371B2
(en)
|
2004-10-14 |
2012-08-21 |
Yale University |
Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer
|
EP1814573B1
(en)
*
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
EP1833504A4
(en)
*
|
2005-01-04 |
2009-08-12 |
Brigham & Womens Hospital |
PERMANENT DELIVERY OF SELF-ARRANGING PEPTIDE NANOFIBER USING THE PDGF
|
US7531533B2
(en)
*
|
2005-01-27 |
2009-05-12 |
Asahi Kasei Pharma Corporation |
6-Membered heterocyclic compound and use thereof
|
JP5014978B2
(ja)
|
2005-01-27 |
2012-08-29 |
旭化成ファーマ株式会社 |
ヘテロ6員環化合物及びその用途
|
CA2597263C
(en)
*
|
2005-02-14 |
2017-01-17 |
Epitopix, Llc |
Polypeptides from staphylococcus aureus and methods of use
|
CA2598889A1
(en)
*
|
2005-02-24 |
2006-08-31 |
Cemines, Inc. |
Compositions and methods for classifying biological samples
|
AU2006227379B2
(en)
|
2005-03-17 |
2011-10-20 |
President And Fellows Of Harvard College |
Synthesis of avrainvillamide, stephacidin B, and analogues thereof
|
FR2885525B1
(fr)
*
|
2005-05-13 |
2009-09-18 |
Urodelia Sa |
Medicament notamment anti-cancereux, destine a des traitements par immunotherapie, en particulier autologue
|
NZ565063A
(en)
*
|
2005-06-13 |
2011-04-29 |
Cleveland Biolabs Inc |
Methods of protecting against apoptosis using lipopeptides
|
US9006487B2
(en)
|
2005-06-15 |
2015-04-14 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
CA2613517A1
(en)
|
2005-06-27 |
2007-01-04 |
Exelixis, Inc. |
Pyrazole based lxr modulators
|
WO2007005249A2
(en)
|
2005-06-29 |
2007-01-11 |
Hyperbranch Medical Technology, Inc. |
Nanoparticles and dendritic-polymer-based hydrogels comprising them
|
US7494788B2
(en)
*
|
2005-07-11 |
2009-02-24 |
Molecular Kinetics, Inc. |
Entropic bristle domain sequences and their use in recombinant protein production
|
US7820790B2
(en)
*
|
2005-07-13 |
2010-10-26 |
Amgen Mountain View Inc. |
IL-6 binding proteins
|
GB0516058D0
(en)
|
2005-08-04 |
2005-09-14 |
Oxford Genome Sciences Uk Ltd |
New protein isoforms and uses thereof
|
GB0517293D0
(en)
|
2005-08-24 |
2005-10-05 |
Cancer Rec Tech Ltd |
Vectors and uses thereof
|
US8703903B2
(en)
*
|
2005-09-15 |
2014-04-22 |
Alk-Abello A/S |
Method for quantification of allergens
|
WO2007044885A2
(en)
*
|
2005-10-11 |
2007-04-19 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
EP1957475A1
(en)
|
2005-10-21 |
2008-08-20 |
Merz Pharma GmbH & Co.KGaA |
Chromenones and their use as modulators of metabotropic glutamate receptors
|
UA96139C2
(uk)
*
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
CA2629461C
(en)
*
|
2005-11-10 |
2016-01-12 |
Anita Melikian |
Substituted quinolones and methods of use
|
WO2007061853A2
(en)
|
2005-11-23 |
2007-05-31 |
Merck & Co., Inc. |
Process for synthesizing 2-phenyl-1h-phenantrho[9,10-d]imidazole derivative
|
KR101049859B1
(ko)
|
2007-11-28 |
2011-07-19 |
대한민국 |
N-말단 pI 값 조절에 의한 수용성 재조합 단백질 생산방법
|
EP2004686A1
(en)
*
|
2006-03-06 |
2008-12-24 |
Symphogen A/S |
Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
|
JP5167155B2
(ja)
|
2006-03-09 |
2013-03-21 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
ペプチド結合に基づく多数の細胞株のプロファイリングに関連した組成物および方法
|
CA2642819C
(en)
|
2006-03-10 |
2015-06-09 |
Warwick Effect Polymers Ltd. |
Sugar polymers
|
WO2007110755A1
(en)
|
2006-03-27 |
2007-10-04 |
Medical Therapies Limited |
Prophylaxis or treatment of cardiovascular inflammation
|
EP2014676B1
(en)
*
|
2006-04-20 |
2012-03-07 |
Kringle Pharma Inc. |
Hgf precursor protein mutant and activated form thereof
|
WO2007131191A2
(en)
*
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
EP2021467A4
(en)
|
2006-05-08 |
2010-01-20 |
Adaerata Ltd Partnership |
CHIMERIC PCSK9 PROTEINS, THESE INCLUDING CELLS AND TEST METHODS THEREWITH
|
JP5564249B2
(ja)
*
|
2006-06-23 |
2014-07-30 |
アレシア・バイオセラピューティクス・インコーポレーテッド |
癌に関与するポリヌクレオチド配列およびポリペプチド配列
|
NL1032064C2
(nl)
*
|
2006-06-27 |
2008-01-02 |
Walraven Holding Bv J Van |
Pijpbeugel met trillingisolerende inlaag.
|
US20090297401A1
(en)
*
|
2006-06-28 |
2009-12-03 |
Rgb Technologies Ab |
Sensor kit and a system for detecting an analyte in a test environment
|
US8198046B2
(en)
*
|
2006-07-11 |
2012-06-12 |
Danisco Us Inc. |
KEX2 cleavage regions of recombinant fusion proteins
|
EP2049144B8
(en)
*
|
2006-07-21 |
2015-02-18 |
ratiopharm GmbH |
Glycosylation of peptides via o-linked glycosylation sequences
|
EP2121747A2
(en)
*
|
2006-07-27 |
2009-11-25 |
Oxford Genome Sciences (UK) Limited |
New protein isoforms and uses thereof
|
US20100120627A1
(en)
*
|
2006-08-02 |
2010-05-13 |
Abdelmajid Belouchi |
Genemap of the human genes associated with psoriasis
|
EP2057465A4
(en)
|
2006-08-09 |
2010-04-21 |
Homestead Clinical Corp |
SPECIFIC ORGAN PROTEINS AND METHODS OF USE
|
EP2066806A2
(fr)
*
|
2006-09-07 |
2009-06-10 |
Laurence Faure |
Test pharmaco diagnostique ciblant l'oncologie
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
US7662820B2
(en)
*
|
2006-10-30 |
2010-02-16 |
Sanrx Pharmaceuticals, Inc. |
Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
|
DE102006051516A1
(de)
*
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
ES2506090T3
(es)
|
2006-12-28 |
2014-10-13 |
Abbvie Inc. |
Inhibidores de la (ADP-ribosa) polimerasa
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
BRPI0806557A2
(pt)
*
|
2007-01-09 |
2014-04-15 |
Cleveland Biolabs Inc |
Processos para aumentar e mobilizar células tronco hematopoiéticas
|
WO2008124483A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
WO2008134761A2
(en)
*
|
2007-04-30 |
2008-11-06 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
US20080306007A1
(en)
*
|
2007-04-30 |
2008-12-11 |
Newcastle Innovation Limited |
Agents for prophylaxis or treatment of neurological related diseases and conditions
|
US8143372B2
(en)
*
|
2007-05-21 |
2012-03-27 |
Children's Hospital & Research Center Oakland |
Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
|
US20090176664A1
(en)
*
|
2007-06-01 |
2009-07-09 |
Keting Chu |
High density peptide arrays containing kinase or phosphatase substrates
|
US8618121B2
(en)
|
2007-07-02 |
2013-12-31 |
Cancer Research Technology Limited |
9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
|
US9018138B2
(en)
*
|
2007-08-16 |
2015-04-28 |
The Johns Hopkins University |
Compositions and methods for generating and screening adenoviral libraries
|
WO2009030237A2
(en)
*
|
2007-09-07 |
2009-03-12 |
Symphogen A/S |
Methods for recombinant manufacturing of anti-rsv antibodies
|
GB0719644D0
(en)
|
2007-10-05 |
2007-11-14 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
WO2009061681A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc |
Antagonists of pgd2 receptors
|
US20110165223A1
(en)
|
2008-01-02 |
2011-07-07 |
The Johns Hopkins University |
Antitumor Immunization by Liposomal Delivery of Vaccine to the Spleen
|
WO2009114942A1
(en)
|
2008-03-20 |
2009-09-24 |
University Health Network |
Thymidylate kinase fusions and uses thereof
|
CA2723824C
(en)
*
|
2008-05-09 |
2022-12-06 |
Surmodics Pharmaceuticals, Inc. |
Biocompatible and biodegradable elastomeric polymers
|
EP2306993B1
(en)
|
2008-05-26 |
2014-03-12 |
Universität Zürich |
Protamine/rna nanoparticles for immunostimulation
|
CN102076661B
(zh)
|
2008-07-03 |
2014-04-09 |
潘米拉制药公司 |
前列腺素d2受体的拮抗剂
|
US8148088B2
(en)
*
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
CA2730428A1
(en)
|
2008-08-01 |
2010-02-04 |
Lixte Biotechnology, Inc. |
Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
|
PL2328893T3
(pl)
|
2008-08-08 |
2013-09-30 |
Synta Pharmaceuticals Corp |
Związki triazolowe modulujące aktywność Hsp90
|
EP2341942A1
(en)
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
EP2362908A4
(en)
*
|
2008-11-03 |
2013-09-18 |
Alethia Biotherapeutics Inc |
ANTIBODIES THAT SPECIFICALLY BLOCK THE BIOLOGICAL ACTIVITY OF A TUMOR ANTIGEN
|
WO2011054112A1
(en)
|
2009-11-03 |
2011-05-12 |
Alethia Biotherapeutics Inc. |
Antibodies that specifically block the biological activity of kidney associated antigen 1
|